LinkedIn Profile

Access Ascentage Pharma historical Linkedin company profile data on number of followers, employee headcount and more
Ticker Symbol Entity Name As Of Date Company Name Followers Employees on Linkedin Link Industry Date Added Date Updated Description Website Specialities Logo HQ.Street HQ.City HQ.State HQ.Country HQ.Postal Headcount change in past 24 months Company Name Sector Industry
private:ascentagepharma 12898756 Nov 18th, 2019 12:00AM Ascentage Pharma 668 74.00 Open Biotechnology Nov 18th, 2019 03:45PM Nov 18th, 2019 03:45PM Ascentage Pharma is a globally-focused, clinical-stage biopharmaceutical company developing novel small molecule therapies for cancers, hepatitis B and age-related diseases. Based on breakthrough technology from the University of Michigan, the Company’s expertise is in designing therapeutics that inhibit protein-protein interactions to restore apoptosis, or programmed cell death, in cancers. Ascentage has built a rich pipeline of six clinical candidates, including a novel, highly potent Bcl-2/Bcl-xL inhibitor, APG-1252, as well as candidates aimed at IAP and MDM2-p53 pathways, and next-generation tyrosine kinase inhibitors. For more information, please visit www.ascentagepharma.com. Open Open 800 King Farm Blvd, suite 300 Rockville Maryland US 20850 Ascentage Pharma Health Care Health Care Equipment & Services
private:ascentagepharma 12898756 Nov 16th, 2019 12:00AM Ascentage Pharma 665 74.00 Open Biotechnology Nov 16th, 2019 03:56PM Nov 16th, 2019 03:56PM Ascentage Pharma is a globally-focused, clinical-stage biopharmaceutical company developing novel small molecule therapies for cancers, hepatitis B and age-related diseases. Based on breakthrough technology from the University of Michigan, the Company’s expertise is in designing therapeutics that inhibit protein-protein interactions to restore apoptosis, or programmed cell death, in cancers. Ascentage has built a rich pipeline of six clinical candidates, including a novel, highly potent Bcl-2/Bcl-xL inhibitor, APG-1252, as well as candidates aimed at IAP and MDM2-p53 pathways, and next-generation tyrosine kinase inhibitors. For more information, please visit www.ascentagepharma.com. Open Open 800 King Farm Blvd, suite 300 Rockville Maryland US 20850 Ascentage Pharma Health Care Health Care Equipment & Services
private:ascentagepharma 12898756 Nov 15th, 2019 12:00AM Ascentage Pharma 665 74.00 Open Biotechnology Nov 15th, 2019 12:38PM Nov 15th, 2019 12:38PM Ascentage Pharma is a globally-focused, clinical-stage biopharmaceutical company developing novel small molecule therapies for cancers, hepatitis B and age-related diseases. Based on breakthrough technology from the University of Michigan, the Company’s expertise is in designing therapeutics that inhibit protein-protein interactions to restore apoptosis, or programmed cell death, in cancers. Ascentage has built a rich pipeline of six clinical candidates, including a novel, highly potent Bcl-2/Bcl-xL inhibitor, APG-1252, as well as candidates aimed at IAP and MDM2-p53 pathways, and next-generation tyrosine kinase inhibitors. For more information, please visit www.ascentagepharma.com. Open Open 800 King Farm Blvd, suite 300 Rockville Maryland US 20850 Ascentage Pharma Health Care Health Care Equipment & Services
private:ascentagepharma 12898756 Nov 14th, 2019 12:00AM Ascentage Pharma 665 74.00 Open Biotechnology Nov 14th, 2019 05:54PM Nov 14th, 2019 05:54PM Ascentage Pharma is a globally-focused, clinical-stage biopharmaceutical company developing novel small molecule therapies for cancers, hepatitis B and age-related diseases. Based on breakthrough technology from the University of Michigan, the Company’s expertise is in designing therapeutics that inhibit protein-protein interactions to restore apoptosis, or programmed cell death, in cancers. Ascentage has built a rich pipeline of six clinical candidates, including a novel, highly potent Bcl-2/Bcl-xL inhibitor, APG-1252, as well as candidates aimed at IAP and MDM2-p53 pathways, and next-generation tyrosine kinase inhibitors. For more information, please visit www.ascentagepharma.com. Open Open 800 King Farm Blvd, suite 300 Rockville Maryland US 20850 Ascentage Pharma Health Care Health Care Equipment & Services
private:ascentagepharma 12898756 Nov 13th, 2019 12:00AM Ascentage Pharma 665 74.00 Open Biotechnology Nov 13th, 2019 01:06PM Nov 13th, 2019 01:06PM Ascentage Pharma is a globally-focused, clinical-stage biopharmaceutical company developing novel small molecule therapies for cancers, hepatitis B and age-related diseases. Based on breakthrough technology from the University of Michigan, the Company’s expertise is in designing therapeutics that inhibit protein-protein interactions to restore apoptosis, or programmed cell death, in cancers. Ascentage has built a rich pipeline of six clinical candidates, including a novel, highly potent Bcl-2/Bcl-xL inhibitor, APG-1252, as well as candidates aimed at IAP and MDM2-p53 pathways, and next-generation tyrosine kinase inhibitors. For more information, please visit www.ascentagepharma.com. Open Open 800 King Farm Blvd, suite 300 Rockville Maryland US 20850 Ascentage Pharma Health Care Health Care Equipment & Services
private:ascentagepharma 12898756 Nov 12th, 2019 12:00AM Ascentage Pharma 663 74.00 Open Biotechnology Nov 12th, 2019 02:48PM Nov 12th, 2019 02:48PM Ascentage Pharma is a globally-focused, clinical-stage biopharmaceutical company developing novel small molecule therapies for cancers, hepatitis B and age-related diseases. Based on breakthrough technology from the University of Michigan, the Company’s expertise is in designing therapeutics that inhibit protein-protein interactions to restore apoptosis, or programmed cell death, in cancers. Ascentage has built a rich pipeline of six clinical candidates, including a novel, highly potent Bcl-2/Bcl-xL inhibitor, APG-1252, as well as candidates aimed at IAP and MDM2-p53 pathways, and next-generation tyrosine kinase inhibitors. For more information, please visit www.ascentagepharma.com. Open Open 800 King Farm Blvd, suite 300 Rockville Maryland US 20850 Ascentage Pharma Health Care Health Care Equipment & Services
private:ascentagepharma 12898756 Nov 11th, 2019 12:00AM Ascentage Pharma 661 73.00 Open Biotechnology Nov 11th, 2019 02:46PM Nov 11th, 2019 02:46PM Ascentage Pharma is a globally-focused, clinical-stage biopharmaceutical company developing novel small molecule therapies for cancers, hepatitis B and age-related diseases. Based on breakthrough technology from the University of Michigan, the Company’s expertise is in designing therapeutics that inhibit protein-protein interactions to restore apoptosis, or programmed cell death, in cancers. Ascentage has built a rich pipeline of six clinical candidates, including a novel, highly potent Bcl-2/Bcl-xL inhibitor, APG-1252, as well as candidates aimed at IAP and MDM2-p53 pathways, and next-generation tyrosine kinase inhibitors. For more information, please visit www.ascentagepharma.com. Open Open 800 King Farm Blvd, suite 300 Rockville Maryland US 20850 Ascentage Pharma Health Care Health Care Equipment & Services
private:ascentagepharma 12898756 Nov 10th, 2019 12:00AM Ascentage Pharma 658 73.00 Open Biotechnology Nov 10th, 2019 05:52PM Nov 10th, 2019 05:52PM Ascentage Pharma is a globally-focused, clinical-stage biopharmaceutical company developing novel small molecule therapies for cancers, hepatitis B and age-related diseases. Based on breakthrough technology from the University of Michigan, the Company’s expertise is in designing therapeutics that inhibit protein-protein interactions to restore apoptosis, or programmed cell death, in cancers. Ascentage has built a rich pipeline of six clinical candidates, including a novel, highly potent Bcl-2/Bcl-xL inhibitor, APG-1252, as well as candidates aimed at IAP and MDM2-p53 pathways, and next-generation tyrosine kinase inhibitors. For more information, please visit www.ascentagepharma.com. Open Open 800 King Farm Blvd, suite 300 Rockville Maryland US 20850 Ascentage Pharma Health Care Health Care Equipment & Services
private:ascentagepharma 12898756 Nov 9th, 2019 12:00AM Ascentage Pharma 656 73.00 Open Biotechnology Nov 9th, 2019 05:20PM Nov 9th, 2019 05:20PM Ascentage Pharma is a globally-focused, clinical-stage biopharmaceutical company developing novel small molecule therapies for cancers, hepatitis B and age-related diseases. Based on breakthrough technology from the University of Michigan, the Company’s expertise is in designing therapeutics that inhibit protein-protein interactions to restore apoptosis, or programmed cell death, in cancers. Ascentage has built a rich pipeline of six clinical candidates, including a novel, highly potent Bcl-2/Bcl-xL inhibitor, APG-1252, as well as candidates aimed at IAP and MDM2-p53 pathways, and next-generation tyrosine kinase inhibitors. For more information, please visit www.ascentagepharma.com. Open Open 800 King Farm Blvd, suite 300 Rockville Maryland US 20850 Ascentage Pharma Health Care Health Care Equipment & Services
private:ascentagepharma 12898756 Nov 8th, 2019 12:00AM Ascentage Pharma 656 73.00 Open Biotechnology Nov 8th, 2019 02:30PM Nov 8th, 2019 02:30PM Ascentage Pharma is a globally-focused, clinical-stage biopharmaceutical company developing novel small molecule therapies for cancers, hepatitis B and age-related diseases. Based on breakthrough technology from the University of Michigan, the Company’s expertise is in designing therapeutics that inhibit protein-protein interactions to restore apoptosis, or programmed cell death, in cancers. Ascentage has built a rich pipeline of six clinical candidates, including a novel, highly potent Bcl-2/Bcl-xL inhibitor, APG-1252, as well as candidates aimed at IAP and MDM2-p53 pathways, and next-generation tyrosine kinase inhibitors. For more information, please visit www.ascentagepharma.com. Open Open 800 King Farm Blvd, suite 300 Rockville Maryland US 20850 Ascentage Pharma Health Care Health Care Equipment & Services

Request a demo to view additional historical data, and much more.

Make fast
queries

No longer rely on engineers to access data; build and share queries with intuitive tools, and derive insights in real time.

Bookmark queries with your team

Save and share custom queries using a private bookmarking feature, accessible to your whole team.

Be first to know with alerts

Scan data points across millions of companies and receive emails when relevant metrics cross critical thresholds.

Visualize data for quick insights

Create custom keyword-based word clouds, charts, and advanced visualizations to quickly analyze the data.

Map competitor locations

Analyze competitor presence and growth over time by overlaying store locations with the Nearby Competitor feature.

Add widgets to your dashboards

Access existing maps, charts, word clouds, and other visualizations to understand your data quickly. Or build custom widgets to view data just the way you want it.